Skip to main content
. 2023 Jun 2;10:1138017. doi: 10.3389/fmed.2023.1138017

Table 3.

General characteristics of study subjects for hypertension complications.

Hypertension complications
Complications p-value Cardiovascular disease p-value Kidney disease p-value Cerebrovascular disease p-value
Yes No Yes No Yes No Yes No
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Group <0.0001 <0.0001 <0.0001 <0.0001
Vulnerable and Outside region 4,100 (37.3) 6,907 (62.8) 2,640 (24.0) 8,367 (76.0) 262 (2.4) 10,745 (97.6) 1928 (17.5) 9,079 (82.5)
Vulnerable and Inside region 6,341 (32.1) 13,419 (67.9) 3,791 (19.2) 15,969 (80.8) 326 (1.7) 19,434 (98.3) 3,330 (16.9) 16,430 (83.1)
Non-vulnerable and Outside region 28,353 (29.9) 66,477 (70.1) 18,768 (19.8) 76,062 (80.2) 2,123 (2.2) 92,707 (97.8) 12,114 (12.8) 82,716 (87.2)
Non-vulnerable and Inside region 33,846 (28.0) 87,047 (72.0) 21,533 (17.8) 99,360 (82.2) 2,184 (1.8) 118,709 (98.2) 15,520 (12.8) 105,373 (87.2)
Sex <0.0001 <0.0001 <0.0001
Male 35,033 (27.9) 90,685 (72.1) 22,562 (18.0) 103,156 (82.0) 2,957 (2.4) 122,761 (97.6) 15,064 (12.0) 110,654 (88.0)
Female 37,607 (31.1) 83,165 (68.9) 24,170 (20.0) 96,602 (80.0) 1938 (1.6) 118,834 (98.4) 17,828 (14.8) 102,944 (85.2)
Income <0.0001 <0.0001 0.2322 <0.0001
Low 11,316 (28.2) 28,777 (71.8) 7,140 (17.8) 32,953 (82.2) 757 (1.9) 39,336 (98.1) 5,204 (13.0) 34,889 (87.0)
Middle 30,428 (28.6) 76,107 (71.4) 19,257 (18.1) 87,278 (81.9) 2,112 (2.0) 104,423 (98.0) 13,981 (13.1) 92,554 (86.9)
High 30,896 (30.9) 68,966 (69.1) 20,335 (20.4) 79,527 (79.6) 2026 (2.0) 97,836 (98.0) 13,707 (13.7) 86,155 (86.3)
Coverage type <0.0001 <0.0001 0.0356 <0.0001
NHI, employed/ self-employed 31,940 (26.1) 90,312 (73.9) 20,970 (17.2) 101,282 (82.9) 2,355 (1.9) 119,897 (98.1) 13,429 (11.0) 108,823 (89.0)
Medical aid 40,700 (32.8) 83,538 (67.2) 25,762 (20.7) 984,765 (79.3) 2,540 (2.0) 121,698 (98.0) 19,463 (15.7) 104,775 (84.3)
Age (years) <0.0001 <0.0001 <0.0001 <0.0001
Under 10 1,159 (40.4) 1712 (59.6) 707 (24.6) 2,164 (75.4) 36 (1.3) 2,835 (98.7) 613 (21.4) 2,258 (78.6)
10–19 58 (4.64) 1,191 (95.4) 45 (3.6) 1,204 (96.4) 7 (0.6) 1,242 (99.4) 7 (0.6) 1,242 (99.4)
20–29 464 (9.49) 4,423 (90.5) 322 (6.6) 4,565 (93.4) 94 (1.9) 4,793 (98.1) 75 (1.5) 4,812 (98.5)
30–39 2,724 (15.18) 15,216 (84.8) 1859 (10.4) 16,081 (89.6) 325 (1.8) 17,615 (98.2) 773 (95.7) 17,167 (4.3)
40–49 10,815 (20.86) 41,024 (79.1) 7,245 (14.0) 44,594 (86.0) 762 (1.5) 51,077 (98.5) 4,066 (92.2) 47,773 (7.8)
50–59 18,910 (27.31) 50,337 (72.7) 12,510 (18.1) 56,737 (81.9) 1,148 (1.7) 68,099 (98.3) 8,025 (88.4) 61,222 (11.6)
60–69 22,621 (38.0) 36,899 (62.0) 14,452 (24.3) 45,086 (75.7) 1,592 (2.7) 57,928 (97.3) 10,995 (81.5) 48,525 (18.5)
Over 70 15,889 (40.8) 23,048 (59.2) 3,592 (24.6) 29,345 (75.4) 931 (2.4) 38,006 (97.6) 8,338 (78.6) 30,599 (21.4)
Charlson comorbidity index <0.0001 <0.0001 <0.0001 <0.0001
0 17,424 (18.0) 79,642 (82.0) 10,626 (11.0) 86,440 (89.0) 1,129 (1.2) 95,937 (98.8) 7,405 (7.6) 89,661 (92.4)
1 22,262 (29.4) 53,543 (70.6) 14,128 (18.6) 61,677 (81.4) 1,486 (2.0) 74,319 (98.0) 9,838 (13.0) 65,967 (87.0)
Over 2 32,954 (44.8) 40,665 (55.2) 21,978 (29.9) 51,641 (70.2) 2,280 (3.1) 71,339 (96.9) 15,649 (21.3) 57,970 (78.7)
Healthcare facility <0.0001 <0.0001 <0.0001 <0.0001
Tertiary Hospital 25,980 (39.7) 39,516 (60.3) 17,411 (26.6) 48,085 (73.4) 1979 (3.0) 63,517 (97.0) 11,107 (17.0) 54,389 (83.0)
Primary Care Hospital 46,660 (25.8) 134,334 (74.2) 29,321 (16.2) 151,673 (83.8) 2,916 (1.6) 178,078 (98.4) 21,785 (12.0) 159,209 (88.0)